Signum Biosciences' Grant - III Round

Signum Biosciences raised a round of funding on September 17, 2007. Investors include New Jersey Commission on Science & Technology.

Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…

Articles about Signum Biosciences' Grant - III Round: